Atlas Trials

Bisphosphonates for Prevention of Post-Denosumab Bone Loss

Clinical trial NCT03396315 · COMPLETED

Trial details

NCT number
NCT03396315
Sponsor
Columbia University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
IOPOsteoporosis
Start date
2018-01-29
Primary completion
2023-06-09
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.